Leerink:" $ALNY Near-term COVID-19 Headwinds most Impactful for $PFE and $IONS; Onpattro is poised to remain the leading player in hATTR polyneuropathy, and we increase Onpattro’s share of the oligo market segment. The 12-month price target for ALNY is $84/share.."